214 related articles for article (PubMed ID: 24420924)
21. The CXCR4 antagonist AMD3100 suppresses hypoxia-mediated growth hormone production in GH3 rat pituitary adenoma cells.
Yoshida D; Koketshu K; Nomura R; Teramoto A
J Neurooncol; 2010 Oct; 100(1):51-64. PubMed ID: 20309720
[TBL] [Abstract][Full Text] [Related]
22. Cullin-4A·DNA damage-binding protein 1 E3 ligase complex targets tumor suppressor RASSF1A for degradation during mitosis.
Jiang L; Rong R; Sheikh MS; Huang Y
J Biol Chem; 2011 Mar; 286(9):6971-8. PubMed ID: 21205828
[TBL] [Abstract][Full Text] [Related]
23. Wnt4 is overexpressed in human pituitary adenomas and is associated with tumor invasion.
Li W; Zhang Y; Zhang M; Huang G; Zhang Q
J Clin Neurosci; 2014 Jan; 21(1):137-41. PubMed ID: 24200887
[TBL] [Abstract][Full Text] [Related]
24. β-Catenin knockdown inhibits pituitary adenoma cell proliferation and invasion via interfering with AKT and gelatinases expression.
Zhao C; Zhang M; Liu W; Wang C; Zhang Q; Li W
Int J Oncol; 2015 Apr; 46(4):1643-50. PubMed ID: 25646597
[TBL] [Abstract][Full Text] [Related]
25. Pituitary adenomas. An immunohistochemical study of hormone production and chromogranin localization.
DeStephano DB; Lloyd RV; Pike AM; Wilson BS
Am J Pathol; 1984 Sep; 116(3):464-72. PubMed ID: 6089568
[TBL] [Abstract][Full Text] [Related]
26. Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors.
Lidhar K; Korbonits M; Jordan S; Khalimova Z; Kaltsas G; Lu X; Clayton RN; Jenkins PJ; Monson JP; Besser GM; Lowe DG; Grossman AB
J Clin Endocrinol Metab; 1999 Oct; 84(10):3823-30. PubMed ID: 10523037
[TBL] [Abstract][Full Text] [Related]
27. Proliferation defects and genome instability in cells lacking Cul4A.
Kopanja D; Stoyanova T; Okur MN; Huang E; Bagchi S; Raychaudhuri P
Oncogene; 2009 Jul; 28(26):2456-65. PubMed ID: 19430492
[TBL] [Abstract][Full Text] [Related]
28. Silencing of HEPN1 is responsible for the aggressive biological behavior of pituitary somatotroph adenomas.
Peng H; Fan J; Wu J; Lang J; Wang J; Liu H; Zhao S; Liao J
Cell Physiol Biochem; 2013; 31(2-3):379-88. PubMed ID: 23548416
[TBL] [Abstract][Full Text] [Related]
29. MiR-219a-2-3p suppresses cell proliferation and promotes apoptosis by targeting MDM2/p53 in pituitary adenomas cells.
Wang Y; Zhao J; Zhang C; Wang P; Huang C; Peng H
Biosci Biotechnol Biochem; 2020 May; 84(5):911-918. PubMed ID: 31959058
[TBL] [Abstract][Full Text] [Related]
30. Specific inhibition of mTOR pathway induces anti-proliferative effect and decreases the hormone secretion in cultured pituitary adenoma cells.
Xie R; He WQ; Shen M; Shou XF; Wang YF; Bao WM; Zhao Y
J Neurooncol; 2015 Oct; 125(1):79-89. PubMed ID: 26297046
[TBL] [Abstract][Full Text] [Related]
31. Lung tumourigenesis in a conditional Cul4A transgenic mouse model.
Yang YL; Hung MS; Wang Y; Ni J; Mao JH; Hsieh D; Au A; Kumar A; Quigley D; Fang LT; Yeh CC; Xu Z; Jablons DM; You L
J Pathol; 2014 Jun; 233(2):113-23. PubMed ID: 24648314
[TBL] [Abstract][Full Text] [Related]
32. Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data.
Buurman H; Saeger W
Eur J Endocrinol; 2006 May; 154(5):753-8. PubMed ID: 16645024
[TBL] [Abstract][Full Text] [Related]
33. In1-ghrelin splicing variant is overexpressed in pituitary adenomas and increases their aggressive features.
Ibáñez-Costa A; Gahete MD; Rivero-Cortés E; Rincón-Fernández D; Nelson R; Beltrán M; de la Riva A; Japón MA; Venegas-Moreno E; Gálvez MÁ; García-Arnés JA; Soto-Moreno A; Morgan J; Tsomaia N; Culler MD; Dieguez C; Castaño JP; Luque RM
Sci Rep; 2015 Mar; 5():8714. PubMed ID: 25737012
[TBL] [Abstract][Full Text] [Related]
34. Cullin 4A (CUL4A), a direct target of miR-9 and miR-137, promotes gastric cancer proliferation and invasion by regulating the Hippo signaling pathway.
Deng J; Lei W; Xiang X; Zhang L; Lei J; Gong Y; Song M; Wang Y; Fang Z; Yu F; Feng M; Sun Z; Chen J; Zhan Z; Xiong J
Oncotarget; 2016 Mar; 7(9):10037-50. PubMed ID: 26840256
[TBL] [Abstract][Full Text] [Related]
35. Involvement of CUL4A in regulation of multidrug resistance to P-gp substrate drugs in breast cancer cells.
Wang Y; Ma G; Wang Q; Wen M; Xu Y; He X; Zhang P; Wang Y; Yang T; Zhan P; Wei G
Molecules; 2013 Dec; 19(1):159-76. PubMed ID: 24368600
[TBL] [Abstract][Full Text] [Related]
36. Small molecule NSC1892 targets the CUL4A/4B-DDB1 interactions and causes impairment of CRL4
Yang C; Wu J; He H; Liu H
Int J Biol Sci; 2020; 16(6):1059-1070. PubMed ID: 32140073
[TBL] [Abstract][Full Text] [Related]
37. siRNA-mediated silencing of bFGF gene inhibits the proliferation, migration, and invasion of human pituitary adenoma cells.
Zhou K; Fan YD; Duysenbi S; Wu PF; Feng ZH; Qian Z; Zhang TR
Tumour Biol; 2017 Jun; 39(6):1010428317704805. PubMed ID: 28656882
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical analysis of p27 (Kip1) in human pituitary glands and in various types of pituitary adenomas.
Komatsubara K; Tahara S; Umeoka K; Sanno N; Teramoto A; Osamura RY
Endocr Pathol; 2001; 12(2):181-8. PubMed ID: 11579684
[TBL] [Abstract][Full Text] [Related]
39. Dysregulation of CUL4A and CUL4B Ubiquitin Ligases in Lung Cancer.
Jia L; Yan F; Cao W; Chen Z; Zheng H; Li H; Pan Y; Narula N; Ren X; Li H; Zhou P
J Biol Chem; 2017 Feb; 292(7):2966-2978. PubMed ID: 27974468
[TBL] [Abstract][Full Text] [Related]
40. ADAM12 induces EMT and promotes cell migration, invasion and proliferation in pituitary adenomas via EGFR/ERK signaling pathway.
Wang J; Zhang Z; Li R; Mao F; Sun W; Chen J; Zhang H; Bartsch JW; Shu K; Lei T
Biomed Pharmacother; 2018 Jan; 97():1066-1077. PubMed ID: 29136943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
